Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

FDA Halts Off-the-Shelf T-Cell Cancer Trials

Stop sign

The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction. . . . → Read More: FDA Halts Off-the-Shelf T-Cell Cancer Trials

Partnership Seeks Lower-Cost Protein Drugs

Chemical atom model

A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs. . . . → Read More: Partnership Seeks Lower-Cost Protein Drugs

Genomic Analysis Shown to Detect Early Pancreatic Cancer

Blood sample tubes

Analysis of genomic and protein indicators in blood samples is shown to detect pancreatic cancer in earlier stages, increasing chances of survival. . . . → Read More: Genomic Analysis Shown to Detect Early Pancreatic Cancer

Off-the-Shelf Stem Cell Company Forms, Gains $72M

Drop of blood

A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds. . . . → Read More: Off-the-Shelf Stem Cell Company Forms, Gains $72M

Gene-Edited Treatments in Works for Safer Cancer Therapies

T-cells and cancer cells

A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies

Immunotherapy Biotech Gains $108M in New Funds

T-cells illustration

A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $108M in New Funds

Small Biz Grant to Advance Cancer Chemotherapy Patch

Cancer on clipboard

A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors. . . . → Read More: Small Biz Grant to Advance Cancer Chemotherapy Patch

AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

Lung cancer illustration

A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease. . . . → Read More: AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

Liquid Biopsy Tech Adapted for Covid-19 Testing

Blood vials

A company developing non-invasive liquid biopsy tests for cancer received NIH funding to extend that technology for quick Covid-19 virus tests. . . . → Read More: Liquid Biopsy Tech Adapted for Covid-19 Testing

NIH Funds Programmable mRNA to Treat Cancer

Breast cancer self exam

National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer. . . . → Read More: NIH Funds Programmable mRNA to Treat Cancer